[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580830":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":37,"collaborators":39,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Checkmab S.r.l.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Healthy Donors",null,"subjects over 18 years of age",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Renata M Grifantini, PhD","CONTACT","0039 00660220","renata.grifantini@checkmab.eu",[19],{"facility":20,"status":21,"city":22,"state":10,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"S.C. Medicina Trasfusionale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","RECRUITING","Milan","20122","Italy","IT",{"type":27,"coordinates":28},"Point",[29,30],9.18951,45.46427,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":35,"phoneExt":10,"email":36},"Daniele Prati, MD","0039 0255034687","daniele.prati@policlinico.mi.it",{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[40],{"name":41,"class":42},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","OTHER","100580830","novel-targets-for-the-development-of-monoclonal-antibodies-for-immunotherapy-100580830",false,"NCT06842407","Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Nuovi Bersagli Per lo Sviluppo di Anticorpi Monoclonali Per Immunoterapia - (Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Immuno-ab","Inclusion Criteria:\n\n* blood donors\n* age of 18 years or more\n* able to sign informed consent\n\nExclusion Criteria:\n\n* age below 18 years\n* Positive for HIV, HCV, HBV\n* not suitable for blood donation\n* not able to understand or sign informed consent",true,"ALL","18 Years",{"count":55,"type":56},600,"ESTIMATED","OBSERVATIONAL","The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.",[9],"2025-02-19",{"date":62,"type":63},"2025-02-24","ACTUAL",{"date":65,"type":63},"2023-04-01",{"date":67,"type":56},"2026-06-30",{"name":5,"class":6},1]